Table 2.
T2DM | Control | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
HOMA-IR* | HSP70 | hs-CRP | BMI | WC | HOMA-IR* | HSP70 | hs-CRP | BMI | WC | |
HOMA-IR* | 1 | – | – | – | – | 1 | – | – | – | – |
HSP70 | 0.175† | 1 | – | – | – | 0.023 | 1 | – | – | – |
hs-CRP | 0.183† | − 0.158† | 1 | – | – | 0.282 | 0.268 | 1 | – | – |
BMI | 0.025 | 0.059 | 0.181† | 1 | – | 0.287 | 0.023 | 0.434† | 1 | – |
WC | − 0.023 | − 0.066 | 0.173† | 0.725$ | 1 | 0.231 | 0. 170 | 0.322† | 0.722$ | 1 |
HOMA-IR, homeostatic model assessment-insulin resistance, hs-CRP: high sensitivity C-reactive protein, HSP70: heat shock protein 70, WC: waist circumference, T2DM: type 2 diabetes
*To attain normal distribution, squared root of HOMA-IR was used as its transformed variable
†Shows significance at the level p < 0.05
$Shows significance at the level p < 0.001